YU51903A - Enolati inhibitora izmene natrijum-vodonik tipa-1 - Google Patents
Enolati inhibitora izmene natrijum-vodonik tipa-1Info
- Publication number
- YU51903A YU51903A YU51903A YUP51903A YU51903A YU 51903 A YU51903 A YU 51903A YU 51903 A YU51903 A YU 51903A YU P51903 A YUP51903 A YU P51903A YU 51903 A YU51903 A YU 51903A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- ethanolates
- inhibitor
- sodium
- exchanger type
- hydrogen exchanger
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Pronalazak se odnosi na enolate NHE-1 inhibitora, N-(5-ciklopropil-1-hinolin-5-il 1H-pirazol-4-karbonil)-gvanidina, kristalne oblike etanolata, postupke dobijanja etanolata, postupke lečenja polazeći od etanolata i metilsulfonatne soli NHE-1 inhibitora dobijenog od etanolata.[The invention relates to ethanolates of the NHE-1 inhibitor, N-(5-cyclopropyl-1-quinolin-5-yl-1H-pyrazole-4-carbonyl)-guanidine, crystalline forms of the ethanolates, methods of preparing the ethalolates, methods of treatment using the ethanolates and the mesylate salt of the NHE-1 inhibitor prepared using the ethanolates.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26545601P | 2001-01-31 | 2001-01-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU51903A true YU51903A (sh) | 2006-05-25 |
Family
ID=23010519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU51903A YU51903A (sh) | 2001-01-31 | 2001-12-21 | Enolati inhibitora izmene natrijum-vodonik tipa-1 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20020147218A1 (sh) |
| EP (1) | EP1355899A1 (sh) |
| JP (1) | JP2004518686A (sh) |
| KR (1) | KR20030069228A (sh) |
| CN (1) | CN1479737A (sh) |
| AR (1) | AR035740A1 (sh) |
| BR (1) | BR0116841A (sh) |
| CA (1) | CA2436539A1 (sh) |
| CZ (1) | CZ20032017A3 (sh) |
| HU (1) | HUP0302860A2 (sh) |
| IL (1) | IL156220A0 (sh) |
| MX (1) | MXPA03006872A (sh) |
| PL (1) | PL363472A1 (sh) |
| RU (1) | RU2242472C1 (sh) |
| WO (1) | WO2002060892A1 (sh) |
| YU (1) | YU51903A (sh) |
| ZA (1) | ZA200303891B (sh) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100449600B1 (ko) * | 1998-02-27 | 2004-09-21 | 화이자 프로덕츠 인크. | 허혈 치료용 ｎ-[(치환된 5원 디아자 이불포화 고리)카르보닐] 구아니딘 유도체 |
| US6441176B1 (en) * | 1999-10-29 | 2002-08-27 | Pfizer Inc. | Method for preparing sodium-hydrogen exchanger type 1 inhibitor |
| UA72002C2 (en) * | 1999-10-29 | 2005-01-17 | Pfizer Prod Inc | Inhibitors crystals of sodium-hydrogen exchange of 1 type, a method for the preparation thereof (variants), a pharmaceuticalcomposition based thereon and a method for the reduction of tissue damage |
| CA2407535A1 (en) * | 2000-04-28 | 2001-11-08 | Pfizer Products Inc. | Sodium-hydrogen exchanger type 1 inhibitor (nhe-1) |
-
2001
- 2001-12-21 JP JP2002561041A patent/JP2004518686A/ja active Pending
- 2001-12-21 KR KR10-2003-7010041A patent/KR20030069228A/ko not_active Application Discontinuation
- 2001-12-21 CA CA002436539A patent/CA2436539A1/en not_active Abandoned
- 2001-12-21 PL PL01363472A patent/PL363472A1/xx not_active Application Discontinuation
- 2001-12-21 EP EP01273557A patent/EP1355899A1/en not_active Withdrawn
- 2001-12-21 YU YU51903A patent/YU51903A/sh unknown
- 2001-12-21 BR BR0116841-0A patent/BR0116841A/pt not_active IP Right Cessation
- 2001-12-21 CN CNA018203930A patent/CN1479737A/zh active Pending
- 2001-12-21 MX MXPA03006872A patent/MXPA03006872A/es unknown
- 2001-12-21 HU HU0302860A patent/HUP0302860A2/hu unknown
- 2001-12-21 WO PCT/IB2001/002652 patent/WO2002060892A1/en not_active Application Discontinuation
- 2001-12-21 IL IL15622001A patent/IL156220A0/xx unknown
- 2001-12-21 CZ CZ20032017A patent/CZ20032017A3/cs unknown
- 2001-12-21 RU RU2003123792/04A patent/RU2242472C1/ru not_active IP Right Cessation
-
2002
- 2002-01-29 AR ARP020100308A patent/AR035740A1/es unknown
- 2002-01-30 US US10/060,601 patent/US20020147218A1/en not_active Abandoned
-
2003
- 2003-05-20 ZA ZA200303891A patent/ZA200303891B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2003123792A (ru) | 2005-01-20 |
| AR035740A1 (es) | 2004-07-07 |
| IL156220A0 (en) | 2003-12-23 |
| CA2436539A1 (en) | 2002-08-08 |
| WO2002060892A8 (en) | 2003-07-31 |
| PL363472A1 (en) | 2004-11-15 |
| CN1479737A (zh) | 2004-03-03 |
| CZ20032017A3 (cs) | 2004-05-12 |
| US20020147218A1 (en) | 2002-10-10 |
| KR20030069228A (ko) | 2003-08-25 |
| RU2242472C1 (ru) | 2004-12-20 |
| BR0116841A (pt) | 2004-02-25 |
| HUP0302860A2 (hu) | 2003-12-29 |
| JP2004518686A (ja) | 2004-06-24 |
| EP1355899A1 (en) | 2003-10-29 |
| ZA200303891B (en) | 2004-05-20 |
| WO2002060892A1 (en) | 2002-08-08 |
| MXPA03006872A (es) | 2003-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20005454D0 (no) | Nye hydroksyindoler, deres anvendelse som fosfodiesterase 4 inhibitorer og fremgangsmÕte for fremstilling derav | |
| CY1108808T1 (el) | Ενωσεις μοτιλιδης | |
| NO20051082L (no) | Antimikrobielle kinoloner, deres sammensetninger og anvendelser | |
| TR200002480T2 (tr) | İzaşemi tedavisi için guanidin türevleri | |
| HK1061854A1 (en) | Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors | |
| TW200615264A (en) | N-(ortho-phenyl)-1-methyl-3-difluoromethylpyrazole-4-carboxanilides and their use as fungicides | |
| DE60112974D1 (en) | Carbolinderivate | |
| NO992821L (no) | Ketobenzamider som calpain-inhibitorer | |
| TW200510325A (en) | 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
| NO20005264L (no) | Heterocyklisk substituerte amider, deres fremstilling og anvendelse | |
| DK1311256T3 (da) | Anvendelse af derivater af valproinsyreamider og 2-valproinsyreamider til behandling eller forebyggelse af smerter og/eller hovedpinelidelser | |
| DK1446380T3 (da) | Formoteroltartrafremgangsmåde og polymorf | |
| ZA200101821B (en) | Use of heteroaryl substituted n-(indole-2-carbonyl-) amides for treatment of infection. | |
| DE69936285D1 (de) | INDOLOi2,1-BöQUINAZOLIN-6,12-DIONE ANTIMALARIA DERIVATE UND METHODEN ZUR BEHANDLUNG VON MALARIA | |
| NO20040210L (no) | Fenylacetamido-tiazolderivater, fremgangsmate for deres fremstilling og deres anvendelse som antitumormidler | |
| NO20034434D0 (no) | Indolinoner substituert i 6-stilling og deres anvendelse som kinase-inhibitorer | |
| DE602004005881D1 (de) | Substituierte pyrazinonverbindungen zur behandlung von entzündungen | |
| DE60131968D1 (de) | PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN | |
| YU51903A (sh) | Enolati inhibitora izmene natrijum-vodonik tipa-1 | |
| NO20021950D0 (no) | Fremgangsmåte for fremstilling av N-(4,5-bis-metansulfonyl-2- metylbenzoyl)-guanidin-hydroklorid | |
| NO20010626D0 (no) | N-substituerte azabicykloheptanderivater, deres fremstilling og anvendelse | |
| MY136854A (en) | Crystalline n-formyl hydroxylamine compounds | |
| MXPA04004685A (es) | Procedimientos para preparar inhibidores de tipo-1 de intercambiador sodio-hidrogeno. | |
| NO20033965L (no) | Caloporosidderivater, fremgangsmåte for deres fremstilling og deres anvendelse | |
| NO20040426L (no) | Nye imidazolidinderivater og deres fremstilling og andvendelse som VLA-4-antagonister. |